Mohammed Khurshed

807 total citations
29 papers, 647 citations indexed

About

Mohammed Khurshed is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Mohammed Khurshed has authored 29 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Genetics and 10 papers in Oncology. Recurrent topics in Mohammed Khurshed's work include Glioma Diagnosis and Treatment (11 papers), Cancer, Hypoxia, and Metabolism (9 papers) and DNA Repair Mechanisms (5 papers). Mohammed Khurshed is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Cancer, Hypoxia, and Metabolism (9 papers) and DNA Repair Mechanisms (5 papers). Mohammed Khurshed collaborates with scholars based in Netherlands, Slovenia and United States. Mohammed Khurshed's co-authors include Cornelis J.F. Van Noorden, Remco J. Molenaar, Vashendriya V.V. Hira, Krissie Lenting, William P. J. Leenders, Johanna W. Wilmink, Tomas Radivoyevitch, Jaroslaw P. Maciejewski, Fonnet E. Bleeker and W. Peter Vandertop and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Mohammed Khurshed

29 papers receiving 637 citations

Peers

Mohammed Khurshed
Satyen H. Gohil United Kingdom
Daniel Trageser United States
Chiara Dell’Agnola Italy
Nadja Zaborsky Austria
Yongshuo Liu China
D Katsaros Italy
Jamie L. DellaGatta United States
Umut H. Toprak Germany
Christopher L. Haga United States
Yoichi Aoki Japan
Satyen H. Gohil United Kingdom
Mohammed Khurshed
Citations per year, relative to Mohammed Khurshed Mohammed Khurshed (= 1×) peers Satyen H. Gohil

Countries citing papers authored by Mohammed Khurshed

Since Specialization
Citations

This map shows the geographic impact of Mohammed Khurshed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Khurshed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Khurshed more than expected).

Fields of papers citing papers by Mohammed Khurshed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed Khurshed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Khurshed. The network helps show where Mohammed Khurshed may publish in the future.

Co-authorship network of co-authors of Mohammed Khurshed

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed Khurshed. A scholar is included among the top collaborators of Mohammed Khurshed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed Khurshed. Mohammed Khurshed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khurshed, Mohammed, Peter Sminia, Johanna W. Wilmink, et al.. (2022). Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells. Cancers. 14(24). 6228–6228. 5 indexed citations
2.
Khurshed, Mohammed, Remco J. Molenaar, Myra E. van Linde, et al.. (2021). A Phase Ib Clinical Trial of Metformin and Chloroquine in Patients with IDH1-Mutated Solid Tumors. Cancers. 13(10). 2474–2474. 24 indexed citations
3.
Khurshed, Mohammed, Vashendriya V.V. Hira, Hanneke W.M. van Laarhoven, et al.. (2019). IDH1‐mutant cancer cells are sensitive to cisplatin and an IDH1‐mutant inhibitor counteracts this sensitivity. The FASEB Journal. 33(S1). 1 indexed citations
4.
Hira, Vashendriya V.V., Barbara Breznik, Miloš Vittori, et al.. (2019). Similarities Between Stem Cell Niches in Glioblastoma and Bone Marrow: Rays of Hope for Novel Treatment Strategies. Journal of Histochemistry & Cytochemistry. 68(1). 33–57. 33 indexed citations
5.
Khurshed, Mohammed, et al.. (2019). Metabolic vulnerabilities in IDH1/2‐mutated solid tumours lead to phase IB/II clinical trial using metformin and chloroquine. The FASEB Journal. 33(S1). 2 indexed citations
6.
Molenaar, Remco J., Tomas Radivoyevitch, Yasunobu Nagata, et al.. (2018). IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors. Clinical Cancer Research. 24(7). 1705–1715. 79 indexed citations
7.
Hira, Vashendriya V.V., et al.. (2018). Comparison of different methodologies and cryostat versus paraffin sections for chromogenic immunohistochemistry. Acta Histochemica. 121(2). 125–134. 35 indexed citations
8.
Breznik, Barbara, Janko Kos, Mohammed Khurshed, et al.. (2018). Cysteine cathepsins B, X and K expression in peri-arteriolar glioblastoma stem cell niches. Journal of Molecular Histology. 49(5). 481–497. 27 indexed citations
9.
Noorden, Cornelis J.F. Van, Mohammed Khurshed, Vashendriya V.V. Hira, & Remco J. Molenaar. (2018). MECHANISMS OF THE IDH1/2 MUTATIONS AND ITS ASSOCIATION WITH CONTRADICTORY SURVIVAL OF GLIOBLASTOMA PATIENTS VERSUS AML PATIENTS. The FASEB Journal. 32(S1). 1 indexed citations
10.
Molenaar, Remco J., Mohammed Khurshed, Vashendriya V.V. Hira, & Cornelis J.F. Van Noorden. (2018). Metabolic Mapping: Quantitative Enzyme Cytochemistry and Histochemistry to Determine the Activity of Dehydrogenases in Cells and Tissues. Journal of Visualized Experiments. 6 indexed citations
11.
Vittori, Miloš, Mohammed Khurshed, Daisy I. Picavet, Cornelis J.F. Van Noorden, & Jasna Štrus. (2018). Development of calcium bodies in Hylonsicus riparius (Crustacea: Isopoda). Arthropod Structure & Development. 47(2). 199–213. 1 indexed citations
12.
Khurshed, Mohammed, Vashendriya V.V. Hira, Hanneke W.M. van Laarhoven, et al.. (2018). IDH1‐mutant cancer cells are sensitive to cisplatin and an IDH1‐mutant inhibitor counteracts this sensitivity. The FASEB Journal. 32(11). 6344–6352. 28 indexed citations
13.
Azaripour, Adriano, Tonny Lagerweij, Wikky Tigchelaar, et al.. (2018). Three-dimensional histochemistry and imaging of human gingiva. Scientific Reports. 8(1). 1647–1647. 23 indexed citations
14.
Hira, Vashendriya V.V., Barbara Breznik, Wikky Tigchelaar, et al.. (2018). Periarteriolar Glioblastoma Stem Cell Niches Express Bone Marrow Hematopoietic Stem Cell Niche Proteins. Journal of Histochemistry & Cytochemistry. 66(3). 155–173. 33 indexed citations
15.
Lenting, Krissie, Mohammed Khurshed, Sanne A. M. van Lith, et al.. (2018). Isocitrate dehydrogenase 1–mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress. The FASEB Journal. 33(1). 557–571. 34 indexed citations
16.
Molenaar, Remco J., Robert J.S. Coelen, Mohammed Khurshed, et al.. (2017). Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1 -mutated or IDH2 -mutated solid tumours. BMJ Open. 7(6). e014961–e014961. 71 indexed citations
17.
Molenaar, Remco J., Dennis Botman, Vashendriya V.V. Hira, et al.. (2015). Radioprotection of IDH1 -Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198. Cancer Research. 75(22). 4790–4802. 116 indexed citations
18.
Molenaar, Remco J., Bhumika J. Patel, Mohammed Khurshed, et al.. (2015). Ex Vivo Experiments Show That IDH1/2-Mutant Inhibitors Can be Safely Used As Adjuvants to Regular Chemotherapy in IDH1/2-Mutated Acute Myeloid Leukemia. Blood. 126(23). 3788–3788. 3 indexed citations
19.
Bhurgri, Yasmin, Irfan Vaziri, M. Ataharul Islam, et al.. (2009). Extranodal non-Hodgkin's lymphomas--a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomas.. PubMed. 9(3). 453–8. 30 indexed citations
20.
Bhurgri, Yasmin, Shahid Pervez, Naila Kayani, et al.. (2009). Time trends in the incidence of cancer cervix in Karachi South, 1995-2002.. PubMed. 9(3). 533–6. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satyen H. Gohil Breakdown of academic impact, for papers by Daniel Trageser Breakdown of academic impact, for papers by Chiara Dell’Agnola Breakdown of academic impact, for papers by Nadja Zaborsky Breakdown of academic impact, for papers by Yongshuo Liu Breakdown of academic impact, for papers by D Katsaros Breakdown of academic impact, for papers by Jamie L. DellaGatta Breakdown of academic impact, for papers by Umut H. Toprak Breakdown of academic impact, for papers by Christopher L. Haga Breakdown of academic impact, for papers by Yoichi Aoki
Rankless by CCL
2026